Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas
Authors
Susanne Fransson
susanne.fransson@clingen.gu.se
Department of Medical and Clinical Genetics, Sahlgrenska Cancer Center, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, SE-405 30, Gothenburg, Sweden
Department of Medical and Clinical Genetics, University of Gothenburg, Sahlgrenska University Hospital, S-413 45, Gothenburg, Sweden
Per Kogner
Department of Women’s and Children’s Health, Childhood Cancer Research Unit, Karolinska Institutet, SE-171 76, Stockholm, Sweden
Tommy Martinsson
Department of Medical and Clinical Genetics, University of Gothenburg, Sahlgrenska University Hospital, S-413 45, Gothenburg, Sweden
Katarina Ejeskär
Department of Medical and Clinical Genetics, Sahlgrenska Cancer Center, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, SE-405 30, Gothenburg, Sweden
School of Life sciences, University of Skövde, SE-541 28, Skövde, Sweden
DOI: https://doi.org/10.1186/1750-2187-8-4 | Journal eISSN: 1750-2187
Language: English
Published on: Apr 18, 2013
Published by: Danny N. Dhanasekaran
In partnership with: Paradigm Publishing Services
Keywords:
© 2013 Susanne Fransson, Per Kogner, Tommy Martinsson, Katarina Ejeskär, published by Danny N. Dhanasekaran
This work is licensed under the Creative Commons Attribution 4.0 License.